Soaring COVID-19 self-test kit sales fuel India underreporting fears | Inquirer News

Soaring COVID-19 self-test kit sales fuel India underreporting fears

/ 11:27 AM January 23, 2022

Soaring COVID-19 self-test kit sales fuel India underreporting fears

In this picture taken on January 18, 2022, an employee conducts a quality control on a Coviself Rapid Antigen Test (RAT) kit to self-test for the Covid-19 coronavirus at the Mylab Discovery Solutions manufacturing facility in Lonavla, some 90 km south-east of Mumbai. – Indian authorities are tightening the rules around the sale of Covid self-tests, as booming sales of the home kits add to underreporting fears during a fresh surge in infections. (Photo by Punit PARANJPE / AFP)

LANOVLA, India — Booming sales of home self-test kits for Covid are prompting Indian authorities to tighten the rules around their sale and fueling long-held fears of underreporting as cases surge.

In the last seven days, India recorded more than 1.9 million new infections — an increase of 57 percent on the previous week, according to data compiled by AFP.


Experts have long worried that actual infections and deaths could be much higher in the country of 1.4 billion people due to widespread underreporting.


Self-test kit manufacturers and pharmacies have reported a surge in demand, particularly in bigger cities and towns.

But with not all kit users believed to be sharing their results, some authorities — including in the crowded financial hub Mumbai — are calling on people to report if they test positive and for pharmacists and manufacturers of self-test equipment to report sales and customers’ details.

Leading local producer Mylab Discovery Solutions, which released the country’s first home test kit last year, has said it ramped up production this month from a base of 200,000 kits a day to two million.

“Whatever we are manufacturing is going into the market immediately,” Mylab’s serology head Shrikant Pawar told AFP.

Experts said demand has been fuelled by the lower cost of the kit, which retails at 250 rupees ($3.40), as well as results in 15 minutes instead of the more accurate PCR test’s 24-48 hours.

Some 13 to 16 million tests are recorded by the ICMR every day, but there are no nationwide figures for the sales or use of self-test kits.


Authorities in Mumbai, home to 20 million people, said 125,000 residents have shared their self-test results with the government since new reporting rules were imposed a week ago.

The city is also trying to keep tabs on asymptomatic contacts, even though national health authorities recently recommended that testing is only required for people showing symptoms after exposure to positive cases.

“Mumbai is one of the most densely populated cities in the world. So suppose a single person is positive, he may infect 20-30 people,” Mumbai’s additional municipal commissioner Suresh Kakani told AFP.

“So even if they are asymptomatic… we should isolate them so that further spread can be checked.”

Mumbai saw daily cases surge above 20,000 two weeks ago before flattening to less than half that figure in recent days, but officials warn hospitalizations could rise in coming weeks.

“You’re seeing test positivity in the big cities in India typically somewhere between 30 and 50 percent,” Gautam Menon, a professor at India’s Ashoka University who has worked on Covid infection modeling, told AFP.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

“It’s an obvious indication that we’re not counting cases accurately. We’re now somewhat far away from understanding the true measure of Covid-19 in India.”


Omicron spread prompts push for home testing 

Gov’t told: Provide free antigen tests, conduct massive contact tracing amid rising COVID cases

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: antigen, COVID-19, Health, India

© Copyright 1997-2024 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.